Successful Treatment of Recurrent Primitive Myxoid Mesenchymal Tumor of Infancy With BCOR Internal Tandem Duplication
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Jan 2017 · 1 min read
In brief
In brief
This case report documents successful treatment of recurrent PMMTI in a 13-month-old with spinal cord compression using doxorubicin-based chemotherapy and proton beam radiotherapy after surgical resection and vincristine/actinomycin failed. The tumor's BCOR ITD mutation links it genetically to clear cell sarcoma of the kidney, suggesting similar treatment approaches may be effective for unresectable PMMTI cases.
Written by the GCMD Library team from the article.
Primitive myxoid mesenchymal tumor of infancy (PMMTI) is a rare tumor with <20 cases reported to date. Recently PMMTI tumors have been found to harbor BCOR internal tandem duplication (ITD), the same genetic alteration detected in clear cell sarcoma of the kidney (CCSK). Complete surgical resection of PMMTI is often curative, but no standard of care has been established for unresectable tumors. We describe a female patient who presented at 13 months of age with a paraspinal mass and spinal cord compression. Histology was consistent with PMMTI, and the tumor was found to harbor BCOR ITD. The patient experienced disease recurrences after multiple surgical resections. After failing to respond to vincristine and actinomycin therapy, the patient demonstrated a nearly complete response to a doxorubicin-containing chemotherapy regimen. The patient's therapy was consolidated with proton beam radiotherapy, and she has remained in remission for >12 months after the conclusion of therapy. This case confirms BCOR ITD as a key finding in PMMTI. The therapeutic approach described here is similar to that used for CCSK and provides a model for the treatment of PMMTI not amenable to complete surgical resection.
Educational content from recorded physician discussions — not medical advice. Talk to your (or your child's) care team about your situation.
Article
MR Imaging of Pediatric Musculoskeletal Tumors:: Recent Advances and Clinical Applications.
Joseph G. Pressey · Published Nov 2026
Article
Comparison of 0.3-mSv CT to Standard-Dose CT for Detection of Lung Nodules in Children and Young Adults With Cancer.
Joseph G. Pressey · Published Nov 2026
Article
Using cancer phenotype sex-specificity to enable unbiased penetrance estimation of SMARCA4 pathogenic variants for small cell carcinoma of the ovary, hypercalcemic type (SCCOHT).
Joseph G. Pressey · Published Nov 2026
Article
Current concepts on the surgical and medical management of osteosarcoma.
Joseph G. Pressey · Published Nov 2026
Article
Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.
Joseph G. Pressey · Published Nov 2026
Article
CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV.
Joseph G. Pressey · Published Nov 2026
Article
Surgical management and surveillance of pediatric appendiceal carcinoid tumor.
Joseph G. Pressey · Published Nov 2026
Article
In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma: A phase 1 study.
Joseph G. Pressey · Published Nov 2026
Article
Zoledronic acid in metastatic osteosarcoma: encouraging progression free survival in four consecutive patients.
Joseph G. Pressey · Published Nov 2026
Article
Comorbidity Burden in a Cohort of Adolescent and Young Adult Patients Diagnosed with Central Nervous System Tumors and Sarcomas.
Joseph G. Pressey · Published Nov 2026
Article
Publications
Joseph G. Pressey · Published Nov 2026
Article
Research
Joseph G. Pressey · Published Nov 2026